[Oral contraceptives, hyperlipoproteinemia and ischemic heart disease]

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026

Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

European heart journal·2026

Related Experiment Videos

[Oral contraceptives, hyperlipoproteinemia and ischemic heart disease]

Related Concept Videos

General characteristics, features of cultivation and antibiotic resistance representatives of mycobacterium fortuitum group representatives (review of literature).

Lipid peroxidation in relation to ageing and the role of endogenous aldehydes in diabetes and other age-related diseases.

[Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease].

[On the history of medical societies in Russia: main trends].

[Under the mask of Crohn's disease. A clinical case report].

[Advanced diagnostic capabilities for cough assessment utilizing the neural network model «CoughScan»: findings from a prospective, comparative observational study].

[Arterial hypertension and bronchial asthma: phenotype, cardiovascular complications, and independent predictors - an analysis of 57,396 patients from a hypertension registry].

[Evaluation of drug therapy in patients before major orthopaedic surgery from the perspective of a general practitioner: a real-world study].

[Screening for Helicobacter pylori infection in patients with acute myocardial infarction and stable coronary artery disease: prevalence and risk factors (a single-center study)].

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial.

Effect of colchicine on C-reactive protein level following hospitalization for myocardial infarction: a meta-analysis of randomized, placebo-controlled trials.

Antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: an individual patient data network meta-analysis.

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

Related Experiment Videos

[Oral contraceptives, hyperlipoproteinemia and ischemic heart disease]

Related Concept Videos

Related Articles